Seeing Is Believing
Currently out of the existing stock ratings of Andrew Mok, 15 are a SELL (10.2%), 38 are a HOLD (25.85%), 94 are a BUY (63.95%).
Analyst Andrew Mok, currently employed at BARCLAYS, carries an average stock price target met ratio of 43.53% that have a potential upside of 11.69% achieved within 89 days. Previously, Andrew Mok worked at UBS.
Andrew Mok’s has documented 300 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CI, Cigna Corp at 05-May-2025.
Analyst best performing recommendations are on ACHC (ACADIA HEALTHCARE COMPANY).
The best stock recommendation documented was for ACHC (ACADIA HEALTHCARE COMPANY) at 3/3/2025. The price target of $35 was fulfilled within 1 day with a profit of $5.26 (13.07%) receiving and performance score of 130.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$100
$4.69 (4.92%)
$100
1 months 1 days ago
(16-Apr-2025)
0/3 (0%)
$8.09 (8.80%)
$165
9 months 18 days ago
(29-Jul-2024)
3/8 (37.5%)
$67.14 (68.61%)
70
Hold
$101
$5.69 (5.97%)
$101
9 months 22 days ago
(25-Jul-2024)
0/7 (0%)
$3.25 (3.32%)
Hold
1 years 1 months 21 days ago
(26-Mar-2024)
5/9 (55.56%)
$12.13 (9.49%)
99
Buy
$100
$4.69 (4.92%)
$139
1 years 1 months 22 days ago
(25-Mar-2024)
7/13 (53.85%)
$7.84 (8.51%)
70
Which stock is Andrew Mok is most bullish on?
Which stock is Andrew Mok is most reserved on?
What Year was the first public recommendation made by Andrew Mok?